Early research (Phase 1)Ended earlyNCT01804530
What this trial is testing
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
Who this might be right for
Solid TumorTumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion MutationsTenosynovial Giant Cell Tumor
Plexxikon 59